GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Staar Surgical Co (FRA:SR3) » Definitions » Change In Receivables

Staar Surgical Co (FRA:SR3) Change In Receivables : €-2.1 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Staar Surgical Co Change In Receivables?

Staar Surgical Co's change in receivables for the quarter that ended in Mar. 2024 was €27.5 Mil. It means Staar Surgical Co's Accounts Receivable declined by €27.5 Mil from Dec. 2023 to Mar. 2024 .

Staar Surgical Co's change in receivables for the fiscal year that ended in Dec. 2023 was €-30.0 Mil. It means Staar Surgical Co's Accounts Receivable increased by €30.0 Mil from Dec. 2022 to Dec. 2023 .

Staar Surgical Co's Accounts Receivable for the quarter that ended in Mar. 2024 was €59.4 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Staar Surgical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 76.21.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Staar Surgical Co's liquidation value for the three months ended in Mar. 2024 was €196.1 Mil.


Staar Surgical Co Change In Receivables Historical Data

The historical data trend for Staar Surgical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Staar Surgical Co Change In Receivables Chart

Staar Surgical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.05 -3.27 -7.85 -18.50 -30.04

Staar Surgical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.04 -28.83 -16.95 16.21 27.45

Staar Surgical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Staar Surgical Co  (FRA:SR3) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Staar Surgical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=59.436/71.168*91
=76.21

2. In Ben Graham's calculation of liquidation value, Staar Surgical Co's accounts receivable are only considered to be worth 75% of book value:

Staar Surgical Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=225.537-91.767+0.75 * 59.436+0.5 * 35.495
=196.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Staar Surgical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Staar Surgical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Staar Surgical Co (FRA:SR3) Business Description

Traded in Other Exchanges
Address
25651 Atlantic Ocean Drive, Lake Forest, CA, USA, 92630
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also make lenses which are used in surgery that treats cataracts. The company offers products are ICLs used in refractive surgery and IOLs used in cataract surgery. The company generated sales are from the ophthalmic surgical product segment.

Staar Surgical Co (FRA:SR3) Headlines

No Headlines